GEM

GEM is a mitogen-induced, immediate-early RGK-family GTPase that localizes to the cytosolic face of the plasma membrane, is phosphorylated on tyrosine, and participates in receptor-mediated signal transduction in T cells and fibroblasts (PMID:7912851). Its G domain binds GDP and GTP with unusually low (micromolar) affinity owing to a distinctive DXWEX motif in switch II that distorts the phosphate-binding site, and its intrinsic GTPase activity is modulated by N- and C-terminal extensions, as revealed by a 2.1 Å crystal structure (PMID:17107948). Ca²⁺/calmodulin binds the C-terminal extension with ~1 nM affinity and inhibits GTP loading, directly coupling calcium signaling to GEM nucleotide cycling (PMID:8810259). GEM also functions as a negative regulator of the Rho–Rho kinase cytoskeletal pathway, inducing cell elongation that is indirectly antagonized by the microtubule-binding activity of tau (PMID:15087445).

1. 1994 High

   Identification of GEM as a mitogen-induced GTPase established the existence of a Ras-related protein linking mitogenic receptor signaling to cell proliferation control.

   Evidence Molecular cloning from stimulated human T cells, subcellular fractionation, tyrosine phosphorylation assay, and overexpression-induced growth arrest in 3T3 fibroblasts

   PMID:7912851

   Open questions at the time

   • Downstream effectors of GEM signaling were not identified
   • The kinase responsible for GEM tyrosine phosphorylation is unknown
   • Whether GEM acts in the GTP- or GDP-bound state for its anti-proliferative effect was not resolved
2. 1996 High

   Demonstration that Ca²⁺/calmodulin binds the C-terminal extension and inhibits GTP loading revealed a direct regulatory link between calcium signaling and GEM nucleotide cycling.

   Evidence Fluorescence titration with dansyl-CaM, W269G point mutant ablating binding, [³²P]CaM overlay, and GTP-binding inhibition assays with recombinant GST-GEM

   PMID:8810259

   Open questions at the time

   • Physiological consequences of CaM-mediated GTP-loading inhibition in cells were not tested
   • Whether CaM binding affects GEM localization or effector interactions is unknown
3. 2004 Medium

   Showing that GEM overexpression induces cell elongation through inhibition of the Rho–Rho kinase pathway provided the first defined cytoskeletal effector axis for this GTPase, and revealed an indirect antagonism by tau through microtubule binding.

   Evidence Transcriptomic profiling of tau-KO mouse brain, overexpression in CHO cells, co-expression rescue with tau and MAPs, direct binding assay (negative)

   PMID:15087445

   Open questions at the time

   • The direct molecular target through which GEM inhibits Rho–Rho kinase signaling was not identified
   • Reliance on overexpression in a single cell type limits generalizability
   • Whether endogenous GEM levels are sufficient to modulate cytoskeletal organization in neurons or T cells is untested
4. 2006 High

   The 2.1 Å crystal structure of the GEM G domain explained the biochemical basis for its unusually low nucleotide affinity and showed how the N- and C-terminal extensions regulate GTPase activity, providing a structural framework for understanding RGK-family divergence from classical Ras.

   Evidence X-ray crystallography of truncated GEM·Mg·GDP complex, nucleotide-binding and GTPase activity assays with truncation mutants

   PMID:17107948

   Open questions at the time

   • No structure of full-length GEM or GEM bound to an effector or calmodulin is available
   • Whether the GTP-bound conformation differs sufficiently to act as a classical switch remains unresolved
   • The structural basis of membrane association is not captured in the truncated construct

• The direct effector(s) mediating GEM's anti-proliferative and cytoskeletal functions, and the in vivo physiological roles of GEM in immune cells and neurons, remain undefined.
• No GEM effector protein has been identified by direct binding
• Loss-of-function studies (knockout, knockdown) in physiologically relevant cell types are lacking
• Regulation of GEM by upstream kinases is uncharacterized